Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice. - Suppr | 超能文献

Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice.

作者信息

Menichetti F

出版信息

J Antimicrob Chemother. 1992 Apr;29(4):461-3. doi: 10.1093/jac/29.4.461.

DOI:10.1093/jac/29.4.461

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice.

J Antimicrob Chemother. 1992 Apr;29(4):461-3. doi: 10.1093/jac/29.4.461.

2

Enterococcus faecium sensitive to teicoplanin but not vancomycin.

J Hosp Infect. 1991 Aug;18(4):322-4. doi: 10.1016/0195-6701(91)90191-a.

3

The role of gram-positive therapy in the neutropenic patient.

J Antimicrob Chemother. 1991 Apr;27 Suppl B:51-60. doi: 10.1093/jac/27.suppl_b.51.

4

Teicoplanin in combination: role in the management of the febrile neutropenic patient.

Eur J Haematol Suppl. 1993;54:25-8. doi: 10.1111/j.1600-0609.1993.tb01902.x.

5

Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.

Infect Dis Clin North Am. 2009 Dec;23(4):965-82, ix. doi: 10.1016/j.idc.2009.06.010.

6

A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.

Br J Haematol. 1990 Dec;76 Suppl 2:35-40. doi: 10.1111/j.1365-2141.1990.tb07934.x.

7

Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.

J Antimicrob Chemother. 1992 Apr;29(4):459-6. doi: 10.1093/jac/29.4.459.

8

Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.

J Antimicrob Chemother. 1991 Aug;28(2):261-9. doi: 10.1093/jac/28.2.261.

9

Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.

Chemotherapy. 2004 Jun;50(2):81-7. doi: 10.1159/000077807.

10

Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.

Eur J Haematol Suppl. 1993;54:18-24. doi: 10.1111/j.1600-0609.1993.tb01901.x.

引用本文的文献

1

Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

BMC Infect Dis. 2009 Jun 4;9:83. doi: 10.1186/1471-2334-9-83.